Genetics of astrocytic tumor progression.

[1]  P. Nilsson,et al.  Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: a study of 69 cases. , 2009, Scandinavian journal of haematology.

[2]  D. Bigner,et al.  Patterns of the early, gross chromosomal changes in malignant human gliomas. , 2008, Hereditas.

[3]  W. Cavenee,et al.  Gliomas in Families , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  I. Petersen,et al.  Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. , 1992, Journal of neurosurgery.

[5]  J. Rey,et al.  Loss of heterozygosity for distal markers on 22q in human gliomas , 1992, International journal of cancer.

[6]  K. Kinzler,et al.  Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer , 1992, Molecular and cellular biology.

[7]  S. Baylin,et al.  Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Mikkelsen,et al.  Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.

[9]  Y. Nakamura,et al.  Accumulation of genetic alterations and progression of primary breast cancer. , 1991, Cancer research.

[10]  L. Loeb,et al.  Mutator phenotype may be required for multistage carcinogenesis. , 1991, Cancer research.

[11]  L. Liotta,et al.  Somatic allelic deletion of nm23 in human cancer. , 1991, Cancer research.

[12]  K. Kinzler,et al.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.

[13]  V. P. Collins,et al.  Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. , 1991, Cancer research.

[14]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[15]  P. Humphrey,et al.  Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. , 1990, Cancer research.

[16]  J. Connolly,et al.  Tumor progression in four mammary epithelial cell lines derived from the same patient. , 1990, Cancer research.

[17]  A. Tanigami,et al.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.

[18]  M. Makuuchi,et al.  Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma , 1990, The Lancet.

[19]  B. Vogelstein,et al.  p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.

[20]  C. James,et al.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. White,et al.  Allelotype of human malignant astrocytoma. , 1990, Cancer research.

[22]  S. Hirohashi,et al.  Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Solt,et al.  Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[24]  Robin C. Allshire,et al.  Telomere reduction in human colorectal carcinoma and with ageing , 1990, Nature.

[25]  D. Housman,et al.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor , 1990, Cell.

[26]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[27]  P. Friedman,et al.  Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. C. Nowell.  Cytogenetics of tumor progression , 1990, Cancer.

[29]  A. Balmain,et al.  Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.

[30]  W. Cavenee,et al.  Suppressors of the malignant phenotype. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[31]  D. Housman,et al.  Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene , 1990, Cell.

[32]  I. Fidler,et al.  Genetic control of cancer metastasis. , 1990, Journal of the National Cancer Institute.

[33]  J. Allalunis-Turner,et al.  Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. , 1990, Cancer research.

[34]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[35]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[36]  Y. Nakamura,et al.  Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. , 1989, Cancer research.

[37]  K. Buetow,et al.  Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Cairncross,et al.  Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. , 1989, Journal of neurosurgery.

[39]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[40]  E. Harlow,et al.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle , 1989, Cell.

[41]  Phang-lang Chen,et al.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.

[42]  T. Pawson,et al.  High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene , 1989, Molecular and cellular biology.

[43]  D. Housman,et al.  Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Kleihues,et al.  Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies , 1989, Cancer.

[45]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[46]  C. James,et al.  Mitotic recombination of chromosome 17 in astrocytomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Jd,et al.  The management of patients with adenocarcinoma and poorly differentiated carcinoma of unknown primary site. , 1989 .

[48]  H. Kitayama,et al.  A ras-related gene with transformation suppressor activity , 1989, Cell.

[49]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[50]  F. Mitelman,et al.  Genetic convergence and divergence in tumor progression. , 1988, Cancer research.

[51]  R. Kerbel,et al.  Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. , 1988, Cancer research.

[52]  B. Modan,et al.  Tumors of the brain and nervous system after radiotherapy in childhood. , 1988, The New England journal of medicine.

[53]  C. James,et al.  Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.

[54]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[55]  J. Haines,et al.  Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. , 1988, The New England journal of medicine.

[56]  J. Minna,et al.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.

[57]  P. Humphrey,et al.  Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. , 1988, Cancer research.

[58]  H. Varmus.  Oncogenes and transcriptional control. , 1987, Science.

[59]  M Terada,et al.  Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Rey,et al.  Chromosomal patterns in human malignant astrocytomas. , 1987, Cancer genetics and cytogenetics.

[61]  J. Barrett,et al.  Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment. , 1987, Environmental health perspectives.

[62]  J. Yokota,et al.  Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. , 1987, Cancer research.

[63]  B. Vogelstein,et al.  Clonal analysis of human colorectal tumors. , 1987, Science.

[64]  P. Leder,et al.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.

[65]  J. Trent,et al.  Identification of an amplified, highly expressed gene in a human glioma. , 1987, Science.

[66]  G. Nicolson,et al.  Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. , 1987, Cancer research.

[67]  W. Lee,et al.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence , 1987, Science.

[68]  C. Croce.  Chromosome translocations and human cancer. , 1986, Cancer research.

[69]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[70]  R. Bjerkvig,et al.  Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. , 1986, Cancer research.

[71]  A. Balmain,et al.  Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis , 1986, Nature.

[72]  R. Weinberg,et al.  The action of oncogenes in the cytoplasm and nucleus. , 1985, Science.

[73]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[74]  A. Brøgger,et al.  Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[75]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[76]  E Farber,et al.  Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes memorial lecture. , 1984, Cancer research.

[77]  E. Farber.  The multistep nature of cancer development. , 1984, Cancer research.

[78]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[79]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[80]  R T Schimke,et al.  Gene amplification, drug resistance, and cancer. , 1984, Cancer research.

[81]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[82]  R. Weinberg,et al.  Cellular oncogenes and multistep carcinogenesis. , 1983, Science.

[83]  A. Sandberg,et al.  Chromosome 6 in malignant melanoma. , 1983, Cancer genetics and cytogenetics.

[84]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[85]  D. Deen,et al.  Development of a 9L rat brain tumor cell multicellular spheroid system and its response to 1,3-bis(2-chloroethyl)-1-nitrosourea and radiation. , 1980, Journal of the National Cancer Institute.

[86]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[87]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[88]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Fraumeni,et al.  Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. , 1969, Journal of the National Cancer Institute.

[90]  J. Fraumeni,et al.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.

[91]  A. Auvinen,et al.  Malignant Tumors of the Central Nervous System , 2020, Occupational Cancers.

[92]  L. R. Foulds,et al.  Tumor Progression: Guest Editorial , 1957 .

[93]  P. Rous,et al.  CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES , 1941, The Journal of experimental medicine.

[94]  H. Scherer.  A CRITICAL REVIEW , 1940, Journal of neurology and psychiatry.

[95]  H. Scherer,et al.  THE FORMS OF GROWTH IN GLIOMAS AND THEIR PRACTICAL SIGNIFICANCE , 1940 .

[96]  E. B. Jackson,et al.  Effects of Colchicine and Radiation on Growth of Normal Tissues and Tumors , 1940 .

[97]  O. Olopade,et al.  Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. , 1992, Cancer research.

[98]  W. Cavenee,et al.  Loss of constitutional heterozygosity in human cancer. , 1991, Annual review of genetics.

[99]  J. Barrett,et al.  Genetic and cellular basis of multistep carcinogenesis. , 1990, Pharmacology & therapeutics.

[100]  F. Collins,et al.  The von Recklinghausen neurofibromatosis region on chromosome 17--genetic and physical maps come into focus. , 1989, American journal of human genetics.

[101]  H. Kitayama,et al.  Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[102]  W. Cavenee,et al.  Genetics and the etiology of solid tumors. , 1988, Important advances in oncology.

[103]  D. Hanahan,et al.  Dissecting multistep tumorigenesis in transgenic mice. , 1988, Annual review of genetics.

[104]  Stanbridge Ej.  Genetic analysis of human malignancy using somatic cell hybrids and monochromosome transfer. , 1988 .

[105]  J. Barrett,et al.  Role of oncogenes and tumor suppressor genes in a multistep model of carcinogenesis. , 1986, Symposium on Fundamental Cancer Research.

[106]  L. Liotta.  Mechanisms of cancer invasion and metastasis. , 1985, Important advances in oncology.

[107]  E. Farber.  The malignant phenotype as a late expression of the carcinogenic process , 1984, Journal of cellular physiology. Supplement.

[108]  A. Ciampi,et al.  A Stem Cell Model of Human Tumor Growth: Implications for Tumor Cell Clonogenic Assays , 1983 .

[109]  J. Bishop.  Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.